Registration - In-house Organization

Canadian Pharmacists Association / Association des Pharmaciens du Canada / Glen Doucet, Chief Executive Officer

Registration Information
In-house Organization name: Canadian Pharmacists Association / Association des Pharmaciens du Canada
Responsible Officer Name: Glen Doucet, Chief Executive Officer 
Responsible Officer Change History
Initial registration start date: 1999-06-01
Registration status: Active
Registration Number: 935843-2
Associated Communications

Total Number of Communication Reports: 175

Monthly communication reports in the last 6 months: 5

Version 1 of 45 (1999-06-01 to 1999-12-22)

Version 1 of 45 (1999-06-01 to 1999-12-22) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: Canadian Pharmacists Association / Association des Pharmaciens du Canada
1785 ALTA VISTA DRIVE
OTTAWA, ON  K1G 3Y6
Canada
Telephone number: 613-523-7877
Fax number: 613-523-0445  
Responsible officer name and position during the period of this registration: JEFF POSTON, EXECUTIVE DIRECTOR  
 
Description of the organization's activities: THE ASSOCIATION ADVOCATES ON ISSUES OF CONCERN TO PHARMACISTS IN ALL AREAS OF PRACTICE. IT IS A NOT FOR PROFIT, VOLUNTARY PROFESSIONAL ASSOCIATION. THE ASSOCIATION FULFILLS ITS MANDATE THROUGH RESEARCH, EDUCATION AND ADVOCACY
Organization's membership or classes of membership: IT IS THE NATIONAL VOLUNTARY ASSOCIATON REPRESENTING OVER 10, 000 PHARMACISTS, WORKING IN ALL FIELDS OF PHARMACY IN ALL PROVINCES AND TERRITORIES. OUR MEMBERS INCLUDE COMMUNITY PHARMACISTS, HOSPITAL PHARMACISTS, ACADEMIC AND RESEARCH PHARMACISTS, STUDENTS, INTERNS AND ADMINISTRATORS.
 
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Organization

Name: JEFF POSTON
Position title: EXECUTIVE DIRECTOR
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 
Name: NOELLE-DOMINIQU WILLEMS
Position title: DIRECTOR OF GOVERNMENT AND PUBLIC AFFAIRS
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Correctional Service of Canada (CSC), Finance Canada (FIN), Health Canada (HC), Immigration and Refugee Board (IRB), Industry Canada, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Royal Canadian Mounted Police (RCMP), Veterans Affairs Canada (VAC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Small Business, Taxation and Finance
 
Subject Matter: Retrospective: ONGOING WORK WITH OTHER PHARMACY ORGANIZATIONS ON NATIONAL PHARMACARE QUESTIONS. APPEARED AT PATENTED MEDICINE PRICES REVIEW BOARD STAKEHOLDERS MEETING. PARTICIPATED IN HEAL COALITION MEETINGS WITH FINANCE MINISTER PAUL MARTIN AND HEALTH MINISTER ALLAN ROCK. PRESENTED BRIEF TO THE INDUSTRY COMMITTEE ON BILL C-54 ( INFORMATION PRIVACY AND ELECTRONIC COMMERCE). SENT A SUBMISSION TO THE HEALTH COMMITTEE ON TRANSPLANT MEDICATIONS. SENT A SUBMISSION TO HEALTH CANADA ON HEALTH PROTECTION LEGISLATION RENEWAL. MET WITH ELINOR CAPLAN, PARLIAMENTARY SECRETARY TO THE MINISTER OF HEALTH, IN CONNECTION WITH PHARMACY AWARENESS WEEK. PRESENTED HER WITH INFORMATION ON THE JUST CHECKING PROGRAM WHICH HAS BEEN DEVELOPED BY THE ASSOCIATION AND FUNDED BY THE POPULATION HEALTH FUND OF HEALTH CANADA.
Subject Matter: Prospective: ONGOING WORK ON NATIONAL PHARMACARE QUESTIONS WITH A VIEW TO PRESENTING A REPORT TO GOVERNMENT BY THE FALL OF 1999. WORK WITH NIHB ON DRUG USE MANAGEMENT STRATEGIES. RESPOND TO REGULATORY AFFAIRS QUESTIONS FROM HEALTH CANADA. FOLLOW UP ON HEALTH PROTECTION LEGISLATION RENEWAL CONSULTATIONS. PARTICIPATION IN DIRECT TO CONSUMER ADVERTISING ISSUE.




Date Modified: